BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36193973)

  • 1. Incidence of symptomatic Covid-19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population.
    Graf I; Herndlhofer S; Kundi M; Greiner G; Sperr M; Hadzijusufovic E; Valent P; Sperr WR
    Eur J Haematol; 2023 Jan; 110(1):67-76. PubMed ID: 36193973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?
    Delgado N; Torres A
    Curr Oncol Rep; 2022 May; 24(5):645-650. PubMed ID: 35218499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population.
    Bonifacio M; Tiribelli M; Miggiano MC; Abruzzese E; Binotto G; Scaffidi L; Cordioli M; Damiani D; Di Bona E; Trawinska MM; Tanasi I; Dubbini MV; Velotta V; Ceccarelli G; Pierdomenico E; Lo Schirico M; Semenzato G; Ruggeri M; Fanin R; Tacconelli E; Pizzolo G; Krampera M
    Cancer Med; 2021 Sep; 10(18):6310-6316. PubMed ID: 34464516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-center study on SARS-CoV-2 infection in patients affected by CML: Vaccination status and bosutinib therapy as possible protective factors for hospitalization.
    Civettini I; Antolini L; Brioschi F; Zambrotta GPM; Guglielmana V; Gambacorti-Passerini C
    Cancer Med; 2023 Apr; 12(8):9662-9667. PubMed ID: 37039261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-Related Symptoms during the SARS-CoV-2 Omicron (B.1.1.529) Variant Surge in Japan.
    Akaishi T; Kushimoto S; Katori Y; Sugawara N; Egusa H; Igarashi K; Fujita M; Kure S; Takayama S; Abe M; Kikuchi A; Ohsawa M; Ishizawa K; Abe Y; Imai H; Inaba Y; Iwamatsu-Kobayashi Y; Nishioka T; Onodera K; Ishii T
    Tohoku J Exp Med; 2022 Sep; 258(2):103-110. PubMed ID: 36002251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
    Breccia M; Abruzzese E; Accurso V; Attolico I; Barulli S; Bergamaschi M; Binotto G; Bocchia M; Bonifacio M; Caocci G; Capodanno I; Castagnetti F; Cavazzini F; Crisà E; Crugnola M; Stella De Candia M; Elena C; Fava C; Galimberti S; Gozzini A; Gugliotta G; Intermesoli T; Iurlo A; La Barba G; Latagliata R; Leonetti Crescenzi S; Levato L; Loglisci G; Lucchesi A; Luciano L; Lunghi F; Luzi D; Malato A; Cristina Miggiano M; Pizzuti M; Pregno P; Rapezzi D; Rege-Cambrin G; Rosti G; Russo S; Sancetta R; Rita Scortechini A; Sorà F; Sportoletti P; Stagno F; Tafuri A; Tiribelli M; Foà R; Saglio G
    Br J Haematol; 2022 Feb; 196(3):559-565. PubMed ID: 34636033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in persons with chronic myeloid leukaemia.
    Li W; Wang D; Guo J; Yuan G; Yang Z; Gale RP; You Y; Chen Z; Chen S; Wan C; Zhu X; Chang W; Sheng L; Cheng H; Zhang Y; Li Q; Qin J; ; Meng L; Jiang Q
    Leukemia; 2020 Jul; 34(7):1799-1804. PubMed ID: 32424293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Omicron BA.5.2-infection and COVID-19 in persons with chronic myeloid leukaemia.
    Cheng F; Xiang H; Gale RP; Chen S; Qu J; Guo H; Li Q; Zhang Y; Li W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11025-11030. PubMed ID: 37337067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
    El-Ashwah S; Salmanton-García J; Bilgin YM; Itri F; Žák P; Weinbergerová B; Verga L; Omrani AS; Silva MGD; Szotkowski T; Marchetti M; Buquicchio C; Nucci M; Schönlein M; Farina F; Besson C; Prezioso L; Nizamuddin S; Dávila-Valls J; Martín-Pérez S; Bonuomo V; Van Doesum J; Tisi MC; Passamonti F; Méndez GA; Meers S; Maertens J; López-García A; Glenthøj A; Bonnani M; Rinaldi I; Ormazabal-Vélez I; Labrador J; Kulasekararaj A; Espigado I; Demirkan F; De Jonge N; Collins GP; Calbacho M; Blennow O; Al-Khabori M; Adžić-Vukičević T; Arellano E; Mišković B; Mladenović M; Nordlander A; Ráčil Z; Ammatuna E; Cordoba R; Hersby DS; Gräfe S; Emarah Z; Hanakova M; Sacchi MV; Ijaz M; Rahimli L; Nunes Rodrigues R; Zambrotta GPM; Marchesi F; Cornely OA; Pagano L
    Leuk Lymphoma; 2024 Feb; 65(2):199-208. PubMed ID: 37966980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biologic diversity of leukemias occurring in patients with mastocytosis.
    Sperr WR; Horny HP; Lechner K; Valent P
    Leuk Lymphoma; 2000 May; 37(5-6):473-86. PubMed ID: 11042508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of Smell and Taste in Asymptomatic and Symptomatic COVID-19 Patients in Sicily, Italy.
    Bianco MR; Modica DM; Drago GD; Azzolina A; Mattina G; De Natale M; Rossi G; Amata M; Canzoneri G; Manganaro G; Di Gregorio F; Russo R; Pricoco S; Saita V; Allegra E
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):182S-185S. PubMed ID: 33350319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study.
    Ector GICG; Huijskens EGW; Blijlevens NMA; Westerweel PE
    Leukemia; 2020 Sep; 34(9):2533-2535. PubMed ID: 32641732
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel computational method for assigning weights of importance to symptoms of COVID-19 patients.
    Alzubaidi MA; Otoom M; Otoum N; Etoom Y; Banihani R
    Artif Intell Med; 2021 Feb; 112():102018. PubMed ID: 33581830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Clinical Characteristics of Coronavirus Disease 2019 Seen at a Testing Centre in Lagos Nigeria.
    Salako AO; Amoo OS; Odubela OO; Osuolale KA; James AB; Oladele DA; Musa AZ; Ige FA; Okwuraiwe AP; Onwuamah CK; Shaibu JO; David AN; Audu RA; Ezechi OC; Odunukwe NN; Salako BL
    West Afr J Med; 2021 Jan; 38(1):54-58. PubMed ID: 33463708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blurring of vision as the only symptom in an undiagnosed case of chronic myeloid leukemia in the COVID-19 era.
    Gumaste P; Vairagyam R
    Indian J Ophthalmol; 2021 Mar; 69(3):768-769. PubMed ID: 33595523
    [No Abstract]   [Full Text] [Related]  

  • 16. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Transmission Among Healthcare Workers in Iran: An Urgent Need for Early Identification and Management.
    Abdolsalehi MR; Mahmoudi S; Badv RS; Pourakbari B; Mirnia K; Mahmoudieh Y; Mamishi S
    Infect Disord Drug Targets; 2022; 22(1):e100821195494. PubMed ID: 35135466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 in cancer patients can be challenging to screen in a resource limited setting.
    Ting FI; Sacdalan DB; Cortez JL; Pacana MAD; Jimeno C
    Cancer Treat Res Commun; 2020; 25():100214. PubMed ID: 33038570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 in otolaryngologist practice: a review of current knowledge.
    Krajewska J; Krajewski W; Zub K; Zatoński T
    Eur Arch Otorhinolaryngol; 2020 Jul; 277(7):1885-1897. PubMed ID: 32306118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using healthcare claims data to analyze the prevalence of BCR-ABL-positive chronic myeloid leukemia in France: A nationwide population-based study.
    Foulon S; Cony-Makhoul P; Guerci-Bresler A; Delord M; Solary E; Monnereau A; Bonastre J; Tubert-Bitter P
    Cancer Med; 2019 Jun; 8(6):3296-3304. PubMed ID: 31038849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.